Fair Value Measurements - Narrative (Details)			12 Months Ended
	Apr. 30, 2024 USD ($) $ / shares shares	Oct. 27, 2023 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) day d $ / shares shares	Dec. 31, 2023 USD ($) shares	Apr. 29, 2022 USD ($)	Sep. 04, 2021 $ / shares	Jul. 22, 2021 shares
Cash and Cash Equivalents [Line Items]
Purchase of warrants (in shares) | shares			666,515				666,516
Expected term (in years)			5 years
Target share price of warrants or rights for redemption (in dollars per share) | $ / shares			$ 594.00
Redemption price per warrant (in dollars per share) | $ / shares			$ 0.33
Number of days for written notice of redemption | d			30
Minimum number of trading days | d			30
Common stock, issued (in shares) | shares			28,016,545	25,978,863
Outstanding loan balance			$ 55,753,000
Other current liabilities			$ 1,211,000
Class A Common Stock Equals Or Exceeds Threshold One
Cash and Cash Equivalents [Line Items]
Minimum number of trading days | d			20
Consecutive trading day threshold | d			30
Public Warrants
Cash and Cash Equivalents [Line Items]
Purchase of warrants (in shares) | shares			457,323				447,223
Private Placement Warrants
Cash and Cash Equivalents [Line Items]
Purchase of warrants (in shares) | shares			209,192				219,293
Perceptive Warrant
Cash and Cash Equivalents [Line Items]
Change in fair value of warrants and contingent liabilities			$ (10,100,000)
Initial Warrant Shares
Cash and Cash Equivalents [Line Items]
Warrant exercise price (in dollars per share) | $ / shares	$ 16.4321
Proceeds from warrant exercises	$ 2,500,000
Volume weighted average price period	1 day
Common stock, issued (in shares) | shares	645,414
Credit Agreement | Secured Debt
Cash and Cash Equivalents [Line Items]
Expected term (in years)		10 years
Revolving credit facility		$ 75,000,000.0
Volume weighted average price period		10 days
Credit Agreement | Secured Debt | Perceptive Warrant
Cash and Cash Equivalents [Line Items]
Number of shares to purchase (in shares) | shares		1,200,000
Credit Agreement | Secured Debt | Initial Warrant Shares
Cash and Cash Equivalents [Line Items]
Warrant exercise price (in dollars per share) | $ / shares		$ 3.1752
Number of shares to purchase (in shares) | shares		800,000
Credit Agreement | Secured Debt | Additional Warrant Shares
Cash and Cash Equivalents [Line Items]
Number of shares to purchase (in shares) | shares		400,000
Common Class A
Cash and Cash Equivalents [Line Items]
Purchase of aggregate private placement warrants (in shares) | shares			1
Warrant exercise price (in dollars per share) | $ / shares						$ 379.50
Target share price of warrants or rights for redemption (in dollars per share) | $ / shares			$ 330.00
Minimum number of trading days | day			20
Consecutive trading day threshold | day			30
Common stock threshold, number of trading days before notice of redemption | day			3
Redemption on warrant holders (in dollars per share) | $ / shares			$ 594.00
Common Class A | Class A Common Stock Equals Or Exceeds Threshold One
Cash and Cash Equivalents [Line Items]
Minimum threshold price of common stock specified to send notice of redemption to the warrant holders (in dollars per share) | $ / shares			594.00
Common Class A | Class A Common Stock Equals Or Exceeds Threshold Two
Cash and Cash Equivalents [Line Items]
Target share price of warrants or rights for redemption (in dollars per share) | $ / shares			330.00
Redemption price per warrant (in dollars per share) | $ / shares			$ 3.30
Number of days for written notice of redemption | day			30
Maximum
Cash and Cash Equivalents [Line Items]
Maturity, at amortized cost			$ 36,600,000
Minimum
Cash and Cash Equivalents [Line Items]
Maturity, at amortized cost			18,300,000
GeneDx
Cash and Cash Equivalents [Line Items]
Change in fair value of warrants and contingent liabilities				$ 900,000
Business combination, contingent consideration arrangements					$ 150,000,000.0
GeneDx | Private Placement Warrants
Cash and Cash Equivalents [Line Items]
Change in fair value of warrants and contingent liabilities			(3,300,000)	200,000
Level 2 | DECD Loan Agreement
Cash and Cash Equivalents [Line Items]
Outstanding loan balance			5,800,000	$ 6,300,000
Other current liabilities			1,200,000
Carrying value			$ 4,900,000